Diagnos Inc. announced that a screening program for Vision-Threatening Diseases (VTD) offered to clientele in AZUR retirement residences. The screening program, in which DIAGNOS wants to gradually introduce its VTD screening services in the 40 residences run by the management firm COGIR, will make it possible to prevent, detect and manage diseases such as age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, cataracts and others.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3 CAD | 0.00% |
|
0.00% | -25.93% |
Jun. 05 | DIAGNOS Raises $0.98 Million in the Second and Final Tranche of a Private Placement of Share Units | MT |
Jun. 05 | DIAGNOS Inc. announced that it has received CAD 1.295821 million in funding | CI |
![Consensus](/images/consensus_flch.gif)
1st Jan change | Capi. | |
---|---|---|
-25.93% | 17.94M | |
-11.48% | 195B | |
+10.30% | 181B | |
+11.75% | 168B | |
+2.17% | 97.42B | |
+45.43% | 90.36B | |
+14.98% | 86.48B | |
+10.94% | 84.88B | |
+6.42% | 50.59B | |
-31.78% | 45.45B |
- Stock Market
- Equities
- ADK Stock
- News DIAGNOS Inc.
- Diagnos Inc. Announces Screening Program for Vision-Threatening Diseases